Advertisement

Strahlentherapie und Onkologie

, Volume 193, Issue 3, pp 200–212 | Cite as

Stereotactic radiotherapy of vestibular schwannoma

Hearing preservation, vestibular function, and local control following primary and salvage radiotherapy
  • Florian PutzEmail author
  • Jan Müller
  • Caterina Wimmer
  • Nicole Goerig
  • Stefan Knippen
  • Heinrich Iro
  • Philipp Grundtner
  • Ilker Eyüpoglu
  • Karl Rössler
  • Sabine Semrau
  • Rainer Fietkau
  • Sebastian Lettmaier
Original Article

Abstract

Objective

The aim of this publication is to present long-term data on functional outcomes and tumor control in a cohort of 107 patients treated with stereotactic radiotherapy (RT) for vestibular schwannoma.

Patients and methods

Included were 107 patients with vestibular schwannoma (primary or recurrent following resection) treated with stereotactic RT (either fractioned or single-dose radiosurgery) between October 2002 and December 2013. Local control and functional outcomes were determined. Analysis of hearing preservation was limited to a subgroup of patients with complete audiometric data collected before treatment and during follow-up. Vestibular function test (FVT) results could be analyzed in a subset of patients and were compared to patient-reported dizziness.

Results

After a mean follow-up of 46.3 months, actuarial local control for the whole cohort was 100% after 2, 97.6% after 5, and 94.1% after 10 years. In patients with primary RT, serviceable hearing was preserved in 72%. Predictors for preservation of serviceable hearing in multivariate analysis were time of follow-up (odds ratio, OR = 0.93 per month; p = 0.021) and pre-RT tumor size (Koos stage I–IIa vs. IIb–IV; OR = 0.15; p = 0.031). Worsening of FVT results was recorded in 17.6% (N = 3). Profound discrepancy of patient-reported dizziness and FVT results was observed after RT. In patients with primary RT, worsening of facial nerve function occurred in 1.7% (N = 1).

Conclusion

Stereotactic RT of vestibular schwannoma provides good functional outcomes and high control rates. Dependence of hearing preservation on time of follow-up and initial tumor stage has to be considered.

Keywords

Radiosurgery Audiometry Hearing loss Dizziness Vestibular function tests 

Stereotaktische Strahlentherapie von Akustikusneurinomen

Hörerhalt, Vestibularfunktion und lokale Kontrolle nach primärer und Salvage-Strahlentherapie

Zusammenfassung

Zielsetzung

Präsentation von Langzeitdaten zu funktionellen Ergebnissen und Tumorkontrolle nach stereotaktischer Radiotherapie (RT) in einer Kohorte von 107 Patienten mit Akustikusneurinom.

Patienten und Methoden

Zwischen Oktober 2002 und Dezember 2013 wurden 107 Patienten mit Akustikusneurinom (primär oder rezidiviert nach vorangegangener Resektion) mittels stereotaktischer RT behandelt (entweder fraktioniert oder als Einzeitradiochirurgie). Bestimmt wurden lokale Kontrolle und funktionelle Ergebnisse. Der Hörerhalt wurde nur bei Patienten mit vollständigen audiometrischen Befunden prä- und posttherapeutisch ermittelt. Objektive Vestibularisdiagnostik (Vestibularfunktionstest, VFT) war in einer Patientensubgruppe verfügbar und wurde der patientenberichteten Schwindelsymptomatik gegenübergestellt.

Ergebnisse

Nach einem mittleren Follow-up von 46,3 Monaten war die aktuarische lokale Kontrolle im Gesamtkollektiv 100 % nach 2, 97,6 % nach 5 bzw. 94,1 % nach 10 Jahren. Bei Patienten mit primärer RT betrug der Erhalt von brauchbarem Hörvermögen 72 %. Prädiktoren hierfür waren in der multivariaten Analyse die Zeit nach Abschluss der RT (Odds Ratio [OR] 0,93 pro Monat; p = 0,021) und die prätherapeutische Tumorgröße (Koos-Stadium I–IIa vs. IIb–IV; OR = 0,15; p = 0,031). Eine Verschlechterung der objektiven Vestibularfunktion wurde bei 17,6 % beobachtet (N = 3). Nach RT ergab sich eine ausgeprägte Diskrepanz zwischen objektiver Vestibularfunktion und subjektiver Schwindelsymptomatik. Bei Patienten mit primärer RT trat bei 1,7 % eine Verschlechterung der Fazialisfunktion auf (N = 1).

Schlussfolgerung

Die stereotaktische RT beim Akustikusneurinom erreicht eine hohe lokale Kontrolle und gute funktionelle Ergebnisse. Die Abhängigkeit des Hörerhalts von der Dauer des Follow-up und der initialen Tumorausdehnung muss berücksichtigt werden.

Schlüsselwörter

Radiochirurgie Audiometrie Hörverlust Schwindel Vestibularfunktionstests 

Notes

Compliance with ethical guidelines

Conflict of interest

F. Putz, J. Müller, C. Wimmer, N. Goerig, S. Knippen, H. Iro, P. Grundtner, I. Eyüpoglu, K. Rössler, S. Semrau, R. Fietkau, and S. Lettmaier declare that they have no competing interests.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Jackler RK, Whinney D (2001) A century of eighth nerve surgery. Otol Neurotol 22(3):401–416CrossRefPubMedGoogle Scholar
  2. 2.
    Maier W, Hassepass F, Aschendorff A, Laszig R (2012) Vestibular schwannoma. Part 2: therapy, prognosis, and rehabilitation. HNO 60(10):927–935. doi: 10.1007/s00106-012-2534-x (quiz 936–927)CrossRefPubMedGoogle Scholar
  3. 3.
    Samii M, Gerganov V, Samii A (2006) Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg 105(4):527–535. doi: 10.3171/jns.2006.105.4.527 CrossRefPubMedGoogle Scholar
  4. 4.
    Abboud T, Regelsberger J, Matschke J, Jowett N, Westphal M, Dalchow C (2015) Long-term vestibulocochlear functional outcome following retro-sigmoid approach to resection of vestibular schwannoma. Eur Arch Otorhinolaryngol 273(3):719–725. doi: 10.1007/s00405-015-3561-5 CrossRefPubMedGoogle Scholar
  5. 5.
    Schmerber S, Palombi O, Boubagra K, Charachon R, Chirossel JP, Gay E (2005) Long-term control of vestibular schwannoma after a translabyrinthine complete removal. Neurosurgery 57(4):693–698 (discussion 693–698)CrossRefPubMedGoogle Scholar
  6. 6.
    Darrouzet V, Martel J, Enee V, Bebear JP, Guerin J (2004) Vestibular schwannoma surgery outcomes: our multidisciplinary experience in 400 cases over 17 years. Laryngoscope 114(4):681–688. doi: 10.1097/00005537-200404000-00016 CrossRefPubMedGoogle Scholar
  7. 7.
    Kaylie DM, Horgan MJ, Delashaw JB, McMenomey SO (2000) A meta-analysis comparing outcomes of microsurgery and gamma knife radiosurgery. Laryngoscope 110(11):1850–1856. doi: 10.1097/00005537-200011000-00016 CrossRefPubMedGoogle Scholar
  8. 8.
    Stangerup SE, Thomsen J, Tos M, Caye-Thomasen P (2010) Long-term hearing preservation in vestibular schwannoma. Otol Neurotol 31(2):271–275. doi: 10.1097/MAO.0b013e3181c34bda CrossRefPubMedGoogle Scholar
  9. 9.
    Breivik CN, Nilsen RM, Myrseth E, Pedersen PH, Varughese JK, Chaudhry AA, Lund-Johansen M (2013) Conservative management or gamma knife radiosurgery for vestibular schwannoma: tumor growth, symptoms, and quality of life. Neurosurgery 73(1):48–56. doi: 10.1227/01.neu.0000429862.50018.b9 (discussion 56–47)CrossRefPubMedGoogle Scholar
  10. 10.
    Fayad JN, Semaan MT, Lin J, Berliner KI, Brackmann DE (2014) Conservative management of vestibular schwannoma: expectations based on the length of the observation period. Otol Neurotol 35(7):1258–1265. doi: 10.1097/mao.0000000000000285 PubMedGoogle Scholar
  11. 11.
    Maier W, Grauvogel TD, Laszig R, Ridder GJ (2011) Value of different strategies in the treatment of vestibular schwannoma: therapeutic aspects and literature analysis. HNO 59(5):425–436. doi: 10.1007/s00106-011-2302-3 CrossRefPubMedGoogle Scholar
  12. 12.
    Kondziolka D, Mousavi SH, Kano H, Flickinger JC, Lunsford LD (2012) The newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation? Neurosurg Focus 33(3):E8. doi: 10.3171/2012.6.focus12192 CrossRefPubMedGoogle Scholar
  13. 13.
    Liu W, Ni M, Jia W, Zhou D, Zhang Q, Jiang Y, Jia G (2015) How to address small- and medium-sized acoustic neuromas with hearing: a systematic review and decision analysis. World Neurosurg 84(2):283–291.e281. doi: 10.1016/j.wneu.2015.03.013 CrossRefPubMedGoogle Scholar
  14. 14.
    Pollock BE, Driscoll CL, Foote RL, Link MJ, Gorman DA, Bauch CD, Mandrekar JN, Krecke KN, Johnson CH (2006) Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 59(1):77–85. doi: 10.1227/01.neu.0000219217.14930.14 (discussion 77–85)CrossRefPubMedGoogle Scholar
  15. 15.
    Myrseth E, Moller P, Pedersen PH, Vassbotn FS, Wentzel-Larsen T, Lund-Johansen M (2005) Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery 56(5):927–935 (discussion 927–935)PubMedGoogle Scholar
  16. 16.
    Myrseth E, Moller P, Pedersen PH, Lund-Johansen M (2009) Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery 64(4):654–661. doi: 10.1227/01.neu.0000340684.60443.55 (discussion 661–653)CrossRefPubMedGoogle Scholar
  17. 17.
    Regis J, Pellet W, Delsanti C, Dufour H, Roche PH, Thomassin JM, Zanaret M, Peragut JC (2002) Functional outcome after gamma knife surgery or microsurgery for vestibular schwannomas. J Neurosurg 97(5):1091–1100. doi: 10.3171/jns.2002.97.5.1091 CrossRefPubMedGoogle Scholar
  18. 18.
    Maniakas A, Saliba I (2012) Microsurgery versus stereotactic radiation for small vestibular schwannomas: a meta-analysis of patients with more than 5 years’ follow-up. Otol Neurotol 33(9):1611–1620. doi: 10.1097/MAO.0b013e31826dbd02 CrossRefPubMedGoogle Scholar
  19. 19.
    Sarmiento JM, Patel S, Mukherjee D, Patil CG (2013) Improving outcomes in patients with vestibular schwannomas: microsurgery versus radiosurgery. J Neurosurg Sci 57(1):23–44PubMedGoogle Scholar
  20. 20.
    Chopra R, Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC (2007) Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 68(3):845–851. doi: 10.1016/j.ijrobp.2007.01.001 CrossRefPubMedGoogle Scholar
  21. 21.
    Hasegawa T, Fujitani S, Katsumata S, Kida Y, Yoshimoto M, Koike J (2005) Stereotactic radiosurgery for vestibular schwannomas: analysis of 317 patients followed more than 5 years. Neurosurgery 57(2):257–265 (discussion 257–265)CrossRefPubMedGoogle Scholar
  22. 22.
    Yang I, Aranda D, Han SJ, Chennupati S, Sughrue ME, Cheung SW, Pitts LH, Parsa AT (2009) Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci 16(6):742–747. doi: 10.1016/j.jocn.2008.09.023 CrossRefPubMedGoogle Scholar
  23. 23.
    Combs SE, Volk S, Schulz-Ertner D, Huber PE, Thilmann C, Debus J (2005) Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Int J Radiat Oncol Biol Phys 63(1):75–81. doi: 10.1016/j.ijrobp.2005.01.055 CrossRefPubMedGoogle Scholar
  24. 24.
    Chan AW, Black P, Ojemann RG, Barker FG 2nd, Kooy HM, Lopes VV, McKenna MJ, Shrieve DC, Martuza RL, Loeffler JS (2005) Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity. Neurosurgery 57(1):60–70 (discussion 60–70)CrossRefPubMedGoogle Scholar
  25. 25.
    Maire JP, Huchet A, Milbeo Y, Darrouzet V, Causse N, Celerier D, Liguoro D, Bebear JP (2006) Twenty years’ experience in the treatment of acoustic neuromas with fractionated radiotherapy: a review of 45 cases. Int J Radiat Oncol Biol Phys 66(1):170–178. doi: 10.1016/j.ijrobp.2006.04.017 CrossRefPubMedGoogle Scholar
  26. 26.
    Koos WT, Day JD, Matula C, Levy DI (1998) Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg 88(3):506–512. doi: 10.3171/jns.1998.88.3.0506 CrossRefPubMedGoogle Scholar
  27. 27.
    Bhandare N, Jackson A, Eisbruch A, Pan CC, Flickinger JC, Antonelli P, Mendenhall WM (2010) Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys 76(3 Suppl):S50–S57. doi: 10.1016/j.ijrobp.2009.04.096 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Dorr W, Herrmann T, Baumann M (2014) Application of organ tolerance dose-constraints in clinical studies in radiation oncology. Strahlenther Onkol 190(7):621–624. doi: 10.1007/s00066-014-0613-5 (626–627)CrossRefPubMedGoogle Scholar
  29. 29.
    Combs SE, Engelhard C, Kopp C, Wiedenmann N, Schramm O, Prokic V, Debus J, Molls M, Grosu AL (2015) Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas – pooled results from 3 large German centers. Radiother Oncol 114(3):378–383. doi: 10.1016/j.radonc.2015.01.011 CrossRefPubMedGoogle Scholar
  30. 30.
    Kopp C, Fauser C, Muller A, Astner ST, Jacob V, Lumenta C, Meyer B, Tonn JC, Molls M, Grosu AL (2011) Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution. Int J Radiat Oncol Biol Phys 80(5):1485–1491. doi: 10.1016/j.ijrobp.2010.04.057 CrossRefPubMedGoogle Scholar
  31. 31.
    Anderson BM, Khuntia D, Bentzen SM, Geye HM, Hayes LL, Kuo JS, Baskaya MK, Badie B, Basavatia A, Pyle GM, Tome WA, Mehta MP (2014) Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery. J Neurooncol 116(1):187–193. doi: 10.1007/s11060-013-1282-4 CrossRefPubMedGoogle Scholar
  32. 32.
    Badakhshi H, Muellner S, Wiener E, Budach V (2014) Image-guided stereotactic radiotherapy for patients with vestibular schwannoma. A clinical study. Strahlenther Onkol 190(6):533–537. doi: 10.1007/s00066-014-0646-9 CrossRefPubMedGoogle Scholar
  33. 33.
    Benghiat H, Heyes G, Nightingale P, Hartley A, Tiffany M, Spooner D, Geh JI, Cruickshank G, Irving RM, Sanghera P (2014) Linear accelerator stereotactic radiosurgery for vestibular schwannomas: a UK series. Clin Oncol 26(6):309–315. doi: 10.1016/j.clon.2014.02.008 CrossRefGoogle Scholar
  34. 34.
    Kranzinger M, Zehentmayr F, Fastner G, Oberascher G, Merz F, Nairz O, Rahim H, Sedlmayer F (2014) Hypofractionated stereotactic radiotherapy of acoustic neuroma: volume changes and hearing results after 89-month median follow-up. Strahlenther Onkol 190(9):798–805. doi: 10.1007/s00066-014-0630-4 CrossRefPubMedGoogle Scholar
  35. 35.
    Boari N, Bailo M, Gagliardi F, Franzin A, Gemma M, del Vecchio A, Bolognesi A, Picozzi P, Mortini P (2014) Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients. J Neurosurg 121(Suppl):123–142. doi: 10.3171/2014.8.gks141506 PubMedGoogle Scholar
  36. 36.
    Champ CE, Shen X, Shi W, Mayekar SU, Chapman K, Werner-Wasik M, Farrell CJ, Gunn V, Downes MB, Liu H, Evans JJ, Andrews DW (2013) Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation. Neurosurgery 73(3):489–496. doi: 10.1227/neu.0000000000000019 CrossRefPubMedGoogle Scholar
  37. 37.
    Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J (2010) Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 76(1):193–200. doi: 10.1016/j.ijrobp.2009.01.064 CrossRefPubMedGoogle Scholar
  38. 38.
    Koh ES, Millar BA, Menard C, Michaels H, Heydarian M, Ladak S, McKinnon S, Rutka JA, Guha A, Pond GR, Laperriere NJ (2007) Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret Hospital. Cancer 109(6):1203–1210. doi: 10.1002/cncr.22499 CrossRefPubMedGoogle Scholar
  39. 39.
    Litre F, Rousseaux P, Jovenin N, Bazin A, Peruzzi P, Wdowczyk D, Colin P (2013) Fractionated stereotactic radiotherapy for acoustic neuromas: a prospective monocenter study of about 158 cases. Radiother Oncol 106(2):169–174. doi: 10.1016/j.radonc.2012.10.013 CrossRefPubMedGoogle Scholar
  40. 40.
    Sawamura Y, Shirato H, Sakamoto T, Aoyama H, Suzuki K, Onimaru R, Isu T, Fukuda S, Miyasaka K (2003) Management of vestibular schwannoma by fractionated stereotactic radiotherapy and associated cerebrospinal fluid malabsorption. J Neurosurg 99(4):685–692. doi: 10.3171/jns.2003.99.4.0685 CrossRefPubMedGoogle Scholar
  41. 41.
    Horan G, Whitfield GA, Burton KE, Burnet NG, Jefferies SJ (2007) Fractionated conformal radiotherapy in vestibular schwannoma: early results from a single centre. Clin Oncol 19(7):517–522. doi: 10.1016/j.clon.2007.02.017 CrossRefGoogle Scholar
  42. 42.
    Woolf DK, Williams M, Goh CL, Henderson DR, Menashy RV, Simpson N, Mastroianni B, Collis CH (2013) Fractionated stereotactic radiotherapy for acoustic neuromas: long-term outcomes. Clin Oncol 25(12):734–738. doi: 10.1016/j.clon.2013.08.002 CrossRefGoogle Scholar
  43. 43.
    Thomas C, Di Maio S, Ma R, Vollans E, Chu C, Clark B, Lee R, McKenzie M, Martin M, Toyota B (2007) Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. J Neurosurg 107(5):917–926. doi: 10.3171/jns-07/11/0917 CrossRefPubMedGoogle Scholar
  44. 44.
    Chung HT, Ma R, Toyota B, Clark B, Robar J, McKenzie M (2004) Audiologic and treatment outcomes after linear accelerator-based stereotactic irradiation for acoustic neuroma. Int J Radiat Oncol Biol Phys 59(4):1116–1121. doi: 10.1016/j.ijrobp.2003.12.032 CrossRefPubMedGoogle Scholar
  45. 45.
    Quist TS, Givens DJ, Gurgel RK, Chamoun R, Shelton C (2015) Hearing preservation after middle fossa vestibular schwannoma removal: Are the results durable? Otolaryngol Head Neck Surg 152(4):706–711. doi: 10.1177/0194599814567874 CrossRefPubMedGoogle Scholar
  46. 46.
    Carlson ML, Jacob JT, Pollock BE, Neff BA, Tombers NM, Driscoll CL, Link MJ (2013) Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. J Neurosurg 118(3):579–587. doi: 10.3171/2012.9.jns12919 CrossRefPubMedGoogle Scholar
  47. 47.
    Hasegawa T, Kida Y, Kato T, Iizuka H, Yamamoto T (2011) Factors associated with hearing preservation after gamma knife surgery for vestibular schwannomas in patients who retain serviceable hearing. J Neurosurg 115(6):1078–1086. doi: 10.3171/2011.7.jns11749 CrossRefPubMedGoogle Scholar
  48. 48.
    Wackym PA, Runge-Samuelson CL, Nash JJ, Poetker DM, Albano K, Bovi J, Michel MA, Friedland DR, Zhu YR, Hannley MT (2010) Gamma knife surgery of vestibular schwannomas: volumetric dosimetry correlations to hearing loss suggest stria vascularis devascularization as the mechanism of early hearing loss. Otol Neurotol 31(9):1480–1487. doi: 10.1097/MAO.0b013e3181f7d7d4 PubMedGoogle Scholar
  49. 49.
    Timmer FC, Hanssens PE, van Haren AE, Mulder JJ, Cremers CW, Beynon AJ, van Overbeeke JJ, Graamans K (2009) Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. Laryngoscope 119(6):1076–1081. doi: 10.1002/lary.20245 CrossRefPubMedGoogle Scholar
  50. 50.
    Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD (2009) Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg 111(4):863–873. doi: 10.3171/2008.12.jns08611 CrossRefPubMedGoogle Scholar
  51. 51.
    Tamura M, Carron R, Yomo S, Arkha Y, Muraciolle X, Porcheron D, Thomassin JM, Roche PH, Regis J (2009) Hearing preservation after gamma knife radiosurgery for vestibular schwannomas presenting with high-level hearing. Neurosurgery 64(2):289–296. doi: 10.1227/01.neu.0000338256.87936.7c (discussion 296)CrossRefPubMedGoogle Scholar
  52. 52.
    Lasak JM, Klish D, Kryzer TC, Hearn C, Gorecki JP, Rine GP (2008) Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose. Otol Neurotol 29(8):1179–1186. doi: 10.1097/MAO.0b013e31818b6639 CrossRefPubMedGoogle Scholar
  53. 53.
    Regis J, Tamura M, Delsanti C, Roche PH, Pellet W, Thomassin JM (2008) Hearing preservation in patients with unilateral vestibular schwannoma after gamma knife surgery. Prog Neurol Surg 21:142–151. doi: 10.1159/000156901 CrossRefPubMedGoogle Scholar
  54. 54.
    Massager N, Nissim O, Delbrouck C, Delpierre I, Devriendt D, Desmedt F, Wikler D, Brotchi J, Levivier M (2007) Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome. J Neurosurg 107(4):733–739. doi: 10.3171/jns-07/10/0733 PubMedGoogle Scholar
  55. 55.
    Bennion NR, Nowak RK, Lyden ER, Thompson RB, Li S, Lin C (2016) Fractionated stereotactic radiation therapy for vestibular schwannomas: dosimetric factors predictive of hearing outcomes. Pract Radiat Oncol 6(5):e155–e162. doi: 10.1016/j.prro.2015.11.015 CrossRefPubMedGoogle Scholar
  56. 56.
    Baschnagel AM, Chen PY, Bojrab D, Pieper D, Kartush J, Didyuk O, Naumann IC, Maitz A, Grills IS (2013) Hearing preservation in patients with vestibular schwannoma treated with gamma knife surgery. J Neurosurg 118(3):571–578. doi: 10.3171/2012.10.jns12880 CrossRefPubMedGoogle Scholar
  57. 57.
    Jacob JT, Carlson ML, Schiefer TK, Pollock BE, Driscoll CL, Link MJ (2014) Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions. Neurosurgery 74(5):466–474. doi: 10.1227/neu.0000000000000299 (discussion 474)CrossRefPubMedGoogle Scholar
  58. 58.
    Kim YH, Kim DG, Han JH, Chung HT, Kim IK, Song SW, Park JH, Kim JW, Kim YH, Park CK, Kim CY, Paek SH, Jung HW (2013) Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion. Int J Radiat Oncol Biol Phys 85(1):61–67. doi: 10.1016/j.ijrobp.2012.03.036 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Florian Putz
    • 1
    Email author
  • Jan Müller
    • 1
  • Caterina Wimmer
    • 1
  • Nicole Goerig
    • 1
  • Stefan Knippen
    • 1
  • Heinrich Iro
    • 2
  • Philipp Grundtner
    • 2
  • Ilker Eyüpoglu
    • 3
  • Karl Rössler
    • 3
  • Sabine Semrau
    • 1
  • Rainer Fietkau
    • 1
  • Sebastian Lettmaier
    • 1
  1. 1.Department of Radiation OncologyFriedrich-Alexander-University Erlangen-NurembergErlangenGermany
  2. 2.Department of Otorhinolaryngology—Head and Neck SurgeryFriedrich-Alexander-University Erlangen-NurembergErlangenGermany
  3. 3.Department of NeurosurgeryFriedrich-Alexander-University Erlangen-NurembergErlangenGermany

Personalised recommendations